Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RAltegravir Switch STudy: Effects on Endothelial Recovery (RASSTER)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by UMC Utrecht.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
S.F.L. van Lelyveld, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT01453933
First received: October 10, 2011
Last updated: December 17, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)